Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.

Tuberculosis (TB) is the leading infectious disease cause of death worldwide. In recent years, stringent measures to contain the spread of SARS-CoV-2 have led to considerable disruptions of healthcare services for TB in many countries. The extent to which these measures have affected TB testing, tre...

Full description

Saved in:
Bibliographic Details
Main Authors: Abigail K de Villiers, Muhammad Osman, Claudio J Struchiner, Anete Trajman, Dheeraj Tumu, Vaibhav V Shah, Guilherme L Werneck, Layana C Alves, Megha Choudhary, Sunita Verma, Sanjay K Mattoo, Sue-Ann Meehan, Urvashi B Singh, Anneke C Hesseling, Florian M Marx
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLOS Global Public Health
Online Access:https://doi.org/10.1371/journal.pgph.0003309
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841533130340564992
author Abigail K de Villiers
Muhammad Osman
Claudio J Struchiner
Anete Trajman
Dheeraj Tumu
Vaibhav V Shah
Guilherme L Werneck
Layana C Alves
Megha Choudhary
Sunita Verma
Sanjay K Mattoo
Sue-Ann Meehan
Urvashi B Singh
Anneke C Hesseling
Florian M Marx
author_facet Abigail K de Villiers
Muhammad Osman
Claudio J Struchiner
Anete Trajman
Dheeraj Tumu
Vaibhav V Shah
Guilherme L Werneck
Layana C Alves
Megha Choudhary
Sunita Verma
Sanjay K Mattoo
Sue-Ann Meehan
Urvashi B Singh
Anneke C Hesseling
Florian M Marx
author_sort Abigail K de Villiers
collection DOAJ
description Tuberculosis (TB) is the leading infectious disease cause of death worldwide. In recent years, stringent measures to contain the spread of SARS-CoV-2 have led to considerable disruptions of healthcare services for TB in many countries. The extent to which these measures have affected TB testing, treatment initiation and outcomes has not been comprehensively assessed. We aimed to estimate TB healthcare service disruptions occurring during the COVID-19 pandemic in Brazil, India, and South Africa. We obtained country-level TB programme and laboratory data and used autoregressive integrated moving average (ARIMA) time-series models to estimate healthcare service disruptions with respect to TB testing, treatment initiation, and treatment outcomes. We quantified disruptions as the percentage difference between TB indicator data observed during the COVID-19 pandemic compared with values for a hypothetical no-COVID scenario, predicted through forecasting of trends during a three-year pre-pandemic period. Annual estimates for 2020-2022 were derived from aggregated monthly data. We estimated that in 2020, the number of bacteriological tests conducted for TB diagnosis was 24.3% (95% uncertainty interval: 8.4%;36.6%) lower in Brazil, 27.8% (19.8;3 4.8%) lower in India, and 32.0% (28.9%;34.9%) lower in South Africa compared with values predicted for the no-COVID scenario. TB treatment initiations were 17.4% (13.9%;20.6%) lower than predicted in Brazil, 43.3% (39.8%;46.4%) in India, and 27.0% (15.2%;36.3%) in South Africa. Reductions in 2021 were less severe compared with 2020. The percentage deaths during TB treatment were 13.7% (8.1%; 19.7%) higher than predicted in Brazil, 1.7% (-8.9%;14.0%) in India and 21.8% (7.4%;39.2%) in South Africa. Our analysis suggests considerable disruptions of TB healthcare services occurred during the early phase of the COVID-19 pandemic in Brazil, India, and South Africa, with at least partial recovery in the following years. Sustained efforts to mitigate the detrimental impact of COVID-19 on TB healthcare services are needed.
format Article
id doaj-art-e9d59c122c7340159307b3bb7f4adb1e
institution Kabale University
issn 2767-3375
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Global Public Health
spelling doaj-art-e9d59c122c7340159307b3bb7f4adb1e2025-01-17T05:49:10ZengPublic Library of Science (PLoS)PLOS Global Public Health2767-33752025-01-0151e000330910.1371/journal.pgph.0003309Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.Abigail K de VilliersMuhammad OsmanClaudio J StruchinerAnete TrajmanDheeraj TumuVaibhav V ShahGuilherme L WerneckLayana C AlvesMegha ChoudharySunita VermaSanjay K MattooSue-Ann MeehanUrvashi B SinghAnneke C HesselingFlorian M MarxTuberculosis (TB) is the leading infectious disease cause of death worldwide. In recent years, stringent measures to contain the spread of SARS-CoV-2 have led to considerable disruptions of healthcare services for TB in many countries. The extent to which these measures have affected TB testing, treatment initiation and outcomes has not been comprehensively assessed. We aimed to estimate TB healthcare service disruptions occurring during the COVID-19 pandemic in Brazil, India, and South Africa. We obtained country-level TB programme and laboratory data and used autoregressive integrated moving average (ARIMA) time-series models to estimate healthcare service disruptions with respect to TB testing, treatment initiation, and treatment outcomes. We quantified disruptions as the percentage difference between TB indicator data observed during the COVID-19 pandemic compared with values for a hypothetical no-COVID scenario, predicted through forecasting of trends during a three-year pre-pandemic period. Annual estimates for 2020-2022 were derived from aggregated monthly data. We estimated that in 2020, the number of bacteriological tests conducted for TB diagnosis was 24.3% (95% uncertainty interval: 8.4%;36.6%) lower in Brazil, 27.8% (19.8;3 4.8%) lower in India, and 32.0% (28.9%;34.9%) lower in South Africa compared with values predicted for the no-COVID scenario. TB treatment initiations were 17.4% (13.9%;20.6%) lower than predicted in Brazil, 43.3% (39.8%;46.4%) in India, and 27.0% (15.2%;36.3%) in South Africa. Reductions in 2021 were less severe compared with 2020. The percentage deaths during TB treatment were 13.7% (8.1%; 19.7%) higher than predicted in Brazil, 1.7% (-8.9%;14.0%) in India and 21.8% (7.4%;39.2%) in South Africa. Our analysis suggests considerable disruptions of TB healthcare services occurred during the early phase of the COVID-19 pandemic in Brazil, India, and South Africa, with at least partial recovery in the following years. Sustained efforts to mitigate the detrimental impact of COVID-19 on TB healthcare services are needed.https://doi.org/10.1371/journal.pgph.0003309
spellingShingle Abigail K de Villiers
Muhammad Osman
Claudio J Struchiner
Anete Trajman
Dheeraj Tumu
Vaibhav V Shah
Guilherme L Werneck
Layana C Alves
Megha Choudhary
Sunita Verma
Sanjay K Mattoo
Sue-Ann Meehan
Urvashi B Singh
Anneke C Hesseling
Florian M Marx
Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
PLOS Global Public Health
title Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
title_full Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
title_fullStr Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
title_full_unstemmed Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
title_short Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data.
title_sort tuberculosis healthcare service disruptions during the covid 19 pandemic in brazil india and south africa a model based analysis of country level data
url https://doi.org/10.1371/journal.pgph.0003309
work_keys_str_mv AT abigailkdevilliers tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT muhammadosman tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT claudiojstruchiner tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT anetetrajman tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT dheerajtumu tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT vaibhavvshah tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT guilhermelwerneck tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT layanacalves tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT meghachoudhary tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT sunitaverma tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT sanjaykmattoo tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT sueannmeehan tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT urvashibsingh tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT annekechesseling tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata
AT florianmmarx tuberculosishealthcareservicedisruptionsduringthecovid19pandemicinbrazilindiaandsouthafricaamodelbasedanalysisofcountryleveldata